[1] Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy

[2] Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

[3] Persistent measles infection in malnourished children

[4] Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo

[5] Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants

[6] Measles vaccination in severely malnourished Sudanese children

[7] Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

[8] Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection

[9] Epidemiology of respiratory syncytial virus infection among infants and children in Chicago

[10] Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society

[11] Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections

[12] Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model

[13] Respiratory syncytial virus infection in human immunodeficiency virus-infected children

[14] The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species

[15] The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2

[16] The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection

[17] The immunologic response to infection with respiratory syncytial virus in infants

[18] Effectiveness of measles vaccine given simultaneously with DTP

[19] Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

[20] Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections

[21] Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

[22] Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children

[23] Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat

[24] Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia

[25] Pathogenesis of bronchiolitis--epidemiologic considerations

[26] Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

[27] Immunization against measles in children at risk for severe disease

[28] Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men

[29] Response to live attenuated measles vaccine in children with severe kwashiorkor

[30] Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex

[31] Defective regulation of immune responses in respiratory syncytial virus infection

[32] Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

[33] Heat treatment of expressed breast milk is a feasible option for feeding HIV-exposed, uninfected children after 6 months of age in rural Zimbabwe

[34] Interferon in nasal secretions from infants with viral respiratory tract infections

[35] An immune control model for viral replication in the CNS during presymptomatic HIV infection

[36] Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients

[37] The role of viruses in the aetiology of community-acquired pneumonia in adults

[38] Rhinoviruses infect the lower airways

[39] Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection